Fate Therapeutics, Inc. (FATE)

Fate Therapeutics Statistics

Total Valuation

FATE has a market cap or net worth of $138.71 million. The enterprise value is -$18.39 million.

Market Cap	138.71M
Enterprise Value	-18.39M

Important Dates

The last earnings date was Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

FATE has 114.63 million shares outstanding. The number of shares has increased by 18.99% in one year.

Current Share Class	114.63M
Shares Outstanding	114.63M
Shares Change (YoY)	+18.99%
Shares Change (QoQ)	+0.49%
Owned by Insiders (%)	1.43%
Owned by Institutions (%)	66.69%
Float	92.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.71
Forward PS	38.68
PB Ratio	0.48
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.81, with a Debt / Equity ratio of 0.29.

Current Ratio	8.81
Quick Ratio	8.69
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -49.23% and return on invested capital (ROIC) is -25.80%.

Return on Equity (ROE)	-49.23%
Return on Assets (ROA)	-23.97%
Return on Invested Capital (ROIC)	-25.80%
Return on Capital Employed (ROCE)	-50.13%
Revenue Per Employee	$73,674
Profits Per Employee	-$971,707
Employee Count	181
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.72% in the last 52 weeks. The beta is 2.32, so FATE's price volatility has been higher than the market average.

Beta (5Y)	2.32
52-Week Price Change	-64.72%
50-Day Moving Average	1.06
200-Day Moving Average	2.02
Relative Strength Index (RSI)	53.45
Average Volume (20 Days)	1,787,570

Short Selling Information

The latest short interest is 12.87 million, so 11.23% of the outstanding shares have been sold short.

Short Interest	12.87M
Short Previous Month	13.34M
Short % of Shares Out	11.23%
Short % of Float	13.94%
Short Ratio (days to cover)	6.27

Income Statement

In the last 12 months, FATE had revenue of $13.34 million and -$175.88 million in losses. Loss per share was -$1.49.

Revenue	13.34M
Gross Profit	-102.19M
Operating Income	-185.75M
Pretax Income	-190.05M
Net Income	-175.88M
EBITDA	-168.28M
EBIT	-185.75M
Loss Per Share	-$1.49

Balance Sheet

The company has $240.43 million in cash and $83.33 million in debt, giving a net cash position of $157.10 million or $1.37 per share.

Cash & Cash Equivalents	240.43M
Total Debt	83.33M
Net Cash	157.10M
Net Cash Per Share	$1.37
Equity (Book Value)	288.41M
Book Value Per Share	2.52
Working Capital	220.06M

Cash Flow

In the last 12 months, operating cash flow was -$123.33 million and capital expenditures -$1.84 million, giving a free cash flow of -$125.17 million.

Operating Cash Flow	-123.33M
Capital Expenditures	-1.84M
Free Cash Flow	-125.17M
FCF Per Share	-$1.09

Margins

Gross Margin	n/a
Operating Margin	-1,392.96%
Pretax Margin	-1,318.93%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FATE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.99%
Shareholder Yield	-18.99%
Earnings Yield	-126.80%
FCF Yield	-90.24%

Analyst Forecast

The average price target for FATE is $4.14, which is 242.15% higher than the current price. The consensus rating is "Hold".

Price Target	$4.14
Price Target Difference	242.15%
Analyst Consensus	Hold
Analyst Count	8
Revenue Growth Forecast (5Y)	38.32%
EPS Growth Forecast (5Y)	-29.49%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FATE has an Altman Z-Score of -4.01 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.01
Piotroski F-Score	4